等待開盤 03-26 09:30:00 美东时间
+0.420
+1.19%
今日重点评级关注:巴克莱:维持Vir Biotechnology"超配"评级,目标价从26美元升至30美元;巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从10美元升至11美元
02-26 09:30
Gainers Everus Construction Group (NYSE:ECG) shares rose 31.0% to $136.5 durin...
02-26 01:05
华盛资讯2月25日讯,Resideo Technologies公布2025财年年度业绩,公司年度营收74.72亿美元,同比增长10.5%,归母净利润亏损5.62亿美元,由盈转亏。
02-25 08:27
华盛资讯2月25日讯,Resideo Technologies公布2025财年Q4业绩,公司Q4营收18.95亿美元,同比增长2.0%,归母净利润1.13亿美元,同比增长841.7%。
02-25 06:31
Resideo Technologies shares are trading higher after the company reported bette...
02-25 05:29
Resideo Q4 net income hits USD 136 million (5.9x) Resideo posted FY 2025 net revenue of USD 7.47 billion, up 11.0% year-over-year, and Adjusted EBITDA of USD 833 million, up 20.0%. The company reported a FY net loss of USD 527 million, which it said was driven by expense associated with terminating
02-25 05:13
Resideo Technologies (NYSE:REZI) is looking for Q1 Adj EPS of $0.58-$0.62 vs $0.57 analyst estimate. sees sales of $1.866 billion-$1.890 billion vs $720.000 million analyst estimate.
02-25 05:12
Resideo Technologies (NYSE:REZI) is looking for FY2026 Adj EPS of $3.00-$3.20 vs $2.79 analyst estimate. sees sales of $7.800 billion-$7.900 billion vs $7.698 billion analyst estimate.
02-25 05:12
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11
Resideo sells Grid Services demand response business to EnergyHub Resideo Technologies said it has sold its Grid Services demand response business, which primarily serves utility clients, to EnergyHub. Financial terms were not disclosed, and Resideo said the divestiture will help it focus on residen
02-21 01:52